External Knee Adduction Moment Predicts Contact Forces in ACL

Share this content:
External Knee Adduction Moment Predicts Contact Forces in ACL
External Knee Adduction Moment Predicts Contact Forces in ACL

FRIDAY, Oct. 21, 2016 (HealthDay News) -- External knee adduction is a significant predictor of medial compartment contact forces in both limbs after anterior cruciate ligament (ACL) injury, according to a study published online Oct. 17 in the Journal of Orthopaedic Research.

Elizabeth Wellsandt, Ph.D., from the University of Nebraska Medical Center in Omaha, and colleagues examined predictive factors of knee joint contact forces after ACL reconstruction. Six months after ACL reconstruction, 30 athletes completed standard gait analysis with surface electromyography.

The researchers found that in both limbs, external knee adduction moment was a significant predictor of medial compartment contact forces. Significant contributions were seen for vertical ground reaction force and co-contraction in the uninvolved limb only.

"The large influence of the knee adduction moment on joint contact forces may provide a critical clue to understanding the mechanical pathway of posttraumatic osteoarthritis after ACL injury," the authors write. "Further work is needed to identify additional driving factors of joint loading in the ACL-injured limb and develop treatment strategies to avert the onset and deleterious consequences of posttraumatic osteoarthritis."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »